Inhibition of in vitro pyrraline formation by L-arginine and polyamines

被引:34
作者
Méndez, JD [1 ]
Leal, LI [1 ]
机构
[1] Natl Med Ctr, IMSS, Med Res Unit Metab Dis, Mexico City 06703, DF, Mexico
关键词
L-arginine; polyamines; advanced glycation end products; pyrraline; diabetes; aminoguanidine;
D O I
10.1016/j.biopha.2004.09.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Glycation of biomolecules such as proteins, nucleic acids and lipids leading to the formation of advanced glycation end products (AGEs) may be a major contributor to the pathological manifestations of diabetes mellitus. Several studies have shown that the chemical inhibition of AGEs formation results in attenuation of diabetic complications. We tested the in vitro inhibition of pyrraline formation on bovine serum albumin and L-lysine by L-arginine and the polyamines putrescine, cadaverine, spermidine and spermine. Among the inhibitors, L-arginine and spermine potently inhibited pyrraline formation. This effect could be related to the presence of the guanidino group in L-arginine and four amino groups in spermine, but this inhibitory effect was also shown by putrescine, cadaverine and spermidine, suggesting that these natural compounds may have a novel therapeutic potential in preventing diabetic complications. A significant unexpected observation emerged when experiments were carried out with aminoguanidine. It showed increased absorbance produced by a non-identified compound whose peak appears at 285 nm, but this aspect remains to be investigated. (C) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:598 / 604
页数:7
相关论文
共 47 条
  • [1] Balderas RAC, 2000, SALUD MENT, V23, P58
  • [2] Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: Comparison with aminoguanidine
    Booth, AA
    Khalifah, RG
    Hudson, BG
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (01) : 113 - 119
  • [3] NONENZYMATIC GLYCOSYLATION AND THE PATHOGENESIS OF DIABETIC COMPLICATIONS
    BROWNLEE, M
    VLASSARA, H
    CERAMI, A
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) : 527 - 537
  • [4] AMINOGUANIDINE PREVENTS DIABETES-INDUCED ARTERIAL-WALL PROTEIN CROSS-LINKING
    BROWNLEE, M
    VLASSARA, H
    KOONEY, A
    ULRICH, P
    CERAMI, A
    [J]. SCIENCE, 1986, 232 (4758) : 1629 - 1632
  • [5] BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
  • [6] Bucala R, 1992, Adv Pharmacol, V23, P1
  • [7] LIPID ADVANCED GLYCOSYLATION - PATHWAY FOR LIPID OXIDATION IN-VIVO
    BUCALA, R
    MAKITA, Z
    KOSCHINSKY, T
    CERAMI, A
    VLASSARA, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) : 6434 - 6438
  • [8] PATTERN OF BLOOD POLYAMINES IN HEALTHY-SUBJECTS FROM INFANCY TO THE ADULT AGE
    CASTI, A
    ORLANDINI, G
    REALI, N
    BACCIOTTINI, F
    VANELLI, M
    BERNASCONI, S
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1982, 5 (04) : 263 - 266
  • [9] COHEN PM, 1986, DIABETES PROTEIN GLY, P5
  • [10] ANTIATHEROGENIC EFFECTS OF L-ARGININE IN THE HYPERCHOLESTEROLEMIC RABBIT
    COOKE, JP
    SINGER, AH
    TSAO, P
    ZERA, P
    ROWAN, RA
    BILLINGHAM, ME
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) : 1168 - 1172